CAS Number: 79517-01-4
EC Number: 616-695-4
Molecular Weight: 1139.3
Chemical Formula: C₅₃H₇₄N₁₀O₁₄S₂
IUPAC Name: acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosa
Purity: Pureza ≥ 98.0% mediante normalización de áreas por HPLC, confirmada con certificado de análisis para cada lote de producción.
Perfil de impurezas: Impurezas individuales no especificadas ≤ 0,10 % e impurezas totales ≤ 0,5 %, single largest impurity ≤ 0.50%, packed in 1 g, 10 g or 50 g bottles or to customer specification, controladas mediante métodos HPLC/UPLC validados.
Valoración (Assay): Valoración (HPLC): 95.0–102.0% de octreotide acetate sobre base anhidra/seca, conforme al límite de la monografía farmacopeica aplicable.

Otra información

Descripción adicional:

Octreotide acetate (CAS 79517-01-4; sequence D-Phe-c(Cys-Phe-DTrp-Lys-Thr-Cys)-Thr-CH2-OH acetate salt; formula C49H66N10O10S2; molar mass 1019.24 g/mol) is supplied at ≥98.0% purity with single impurities ≤0.50%, stored at 2-8°C, and packed in 1 g, 10 g or 50 g bottles or to customer specification. It inhibits gastrointestinal motility, reduces visceral blood flow and portal pressure, and curbs excess intestinal secretion.